drugset / Trial / NCT03830645

PRP in 2ry Spontaneous Pneumothorax

NCT03830645

Phase 1 Unknown 40 enrolled Zagazig University
NaSingle-groupOpen-labelTreatment

Summary

secondary spontaneous pneumothorax patients will be enrolled ,all of them will receive PRP with different doses and schedules

Timeline

Start
2018-11-05
Primary completion
2020-11
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified Other

Indications